These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10950936)

  • 1. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I.
    Romano M; Danek GM; Baralle FE; Mazzotti R; Filocamo M
    Blood Cells Mol Dis; 2000 Jun; 26(3):171-6. PubMed ID: 10950936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two novel GBA mutations causing Gaucher disease that lead to aberrant RNA species by using functional splicing assays.
    Dominissini S; Buratti E; Bembi B; Baralle M; Pittis MG
    Hum Mutat; 2006 Jan; 27(1):119. PubMed ID: 16329099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients.
    Filocamo M; Mazzotti R; Stroppiano M; Seri M; Giona F; Parenti G; Regis S; Corsolini F; Zoboli S; Gatti R
    Hum Mutat; 2002 Sep; 20(3):234-5. PubMed ID: 12204005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new gene-pseudogene fusion allele due to a recombination in intron 2 of the glucocerebrosidase gene causes Gaucher disease.
    Cormand B; Díaz A; Grinberg D; Chabás A; Vilageliu L
    Blood Cells Mol Dis; 2000 Oct; 26(5):409-16. PubMed ID: 11112377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
    Choy FY; Wei C; Levin D
    Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of Gaucher disease in a Vietnamese-Czechoslovak patient with high residual glucocerebrosidase activity.
    Choy FY; Woo M; Der Kaloustian VM
    Am J Med Genet; 1991 Jun; 39(4):466-71. PubMed ID: 1877626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease.
    Di Leo E; Panico F; Tarugi P; Battisti C; Federico A; Calandra S
    Hum Mutat; 2004 Nov; 24(5):440. PubMed ID: 15459971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptic splice site in the complementary DNA of glucocerebrosidase causes inefficient expression.
    Bukovac SW; Bagshaw RD; Rigat BA; Callahan JW; Clarke JT; Mahuran DJ
    Anal Biochem; 2008 Oct; 381(2):276-8. PubMed ID: 18619939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.
    Klima H; Ullrich K; Aslanidis C; Fehringer P; Lackner KJ; Schmitz G
    J Clin Invest; 1993 Dec; 92(6):2713-8. PubMed ID: 8254026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations.
    Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA
    Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
    Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
    J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles.
    Tayebi N; Stern H; Dymarskaia I; Herman J; Sidransky E
    Am J Med Genet; 1996 Dec; 66(3):316-9. PubMed ID: 8985494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
    Stone DL; Tayebi N; Orvisky E; Stubblefield B; Madike V; Sidransky E
    Hum Mutat; 2000; 15(2):181-8. PubMed ID: 10649495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
    Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
    Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel RNA splicing mutation in Japanese patients with Wilson disease.
    Shimizu N; Kawase C; Nakazono H; Hemmi H; Shimatake H; Aoki T
    Biochem Biophys Res Commun; 1995 Dec; 217(1):16-20. PubMed ID: 8526905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent.
    Choy FY; Wei C; Applegarth DA; McGillivray BC
    Am J Med Genet; 1994 Jun; 51(2):156-60. PubMed ID: 7916532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
    Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
    Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.